TUI AG NA O.N.
Commented by Fabian Lorenz on May 4th, 2023 | 08:10 CEST
Buy or sell? TUI, BASF and Defence Therapeutics
BASF share a buy or sell? Analyst opinions on the chemical giant diverge widely. The DAX-listed company has just reported quarterly figures, but it did not provide clarity about the prospects. However, some speculate on a forecast increase. Analysts have not commented on TUI for quite some time. After the turbulence surrounding the capital increase, new impulses are being sought, perhaps through a deal with the German government? There is plenty of impetus for rising prices at Defence Therapeutics. The biotech high-flyer of the past months is increasingly positioning itself as a partner to BioNTech, Moderna and Co - and perhaps even a takeover candidate.
Read
Commented by André Will-Laudien on April 27th, 2023 | 09:00 CEST
Artificial intelligence is the new gold - TUI, Lufthansa and Star Navigation Systems with 100% chance!
The world of flight and travel is in a state of upheaval as artificial intelligence enters the decision-making world of humans. Quite unconsciously, various recommendations are creeping into the email boxes of citizens based on the usage behavior derived from Big Data collected over the past months or even years. The well-known IT giants collect data from our consumption and payment habits, analyze websites visited and build targeted advertising in the background, which wanders across our screens quasi "at random" in all situations in life. Although no one is really surprised here any more, 30% of our purchasing behaviour now comes from the Big Data machinery. Some stocks are making a name for themselves here.
Read